Cotreatment of dose-dependent ononin with PTX significantly increased the rate of apoptosis by increasing the expression of apoptosis markers, cleaved-PARP, cleaved-caspase 3, and cleaved-caspase 9 resulting in NSCLC cell death. The gene discussed is CASP3; the disease is non-small cell lung carcinoma.